AXIM Biotechnologies Inc (AXIM)
0.009
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
AXIM Biotechnologies Enterprise Value: 8.989M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 8.989M |
| May 30, 2024 | 8.989M |
| May 29, 2024 | 8.989M |
| May 28, 2024 | 8.930M |
| May 24, 2024 | 9.470M |
| May 23, 2024 | 9.572M |
| May 22, 2024 | 9.28M |
| May 21, 2024 | 9.863M |
| May 20, 2024 | 9.863M |
| May 17, 2024 | 9.150M |
| May 16, 2024 | 9.150M |
| May 15, 2024 | 9.010M |
| May 14, 2024 | 8.788M |
| May 13, 2024 | 9.150M |
| May 10, 2024 | 9.281M |
| May 09, 2024 | 9.651M |
| May 08, 2024 | 9.178M |
| May 07, 2024 | 9.178M |
| May 06, 2024 | 9.423M |
| May 03, 2024 | 9.554M |
| May 02, 2024 | 9.762M |
| May 01, 2024 | 10.54M |
| April 30, 2024 | 10.49M |
| April 29, 2024 | 10.21M |
| April 26, 2024 | 10.18M |
| Date | Value |
|---|---|
| April 25, 2024 | 9.776M |
| April 24, 2024 | 9.233M |
| April 23, 2024 | 9.400M |
| April 22, 2024 | 9.902M |
| April 19, 2024 | 10.54M |
| April 18, 2024 | 10.68M |
| April 17, 2024 | 10.68M |
| April 16, 2024 | 10.23M |
| April 15, 2024 | 10.71M |
| April 12, 2024 | 10.43M |
| April 11, 2024 | 9.618M |
| April 10, 2024 | 9.651M |
| April 09, 2024 | 9.567M |
| April 08, 2024 | 9.846M |
| April 05, 2024 | 9.540M |
| April 04, 2024 | 9.846M |
| April 03, 2024 | 10.07M |
| April 02, 2024 | 9.233M |
| April 01, 2024 | 9.567M |
| March 31, 2024 | 9.567M |
| March 28, 2024 | 8.334M |
| March 27, 2024 | 8.433M |
| March 26, 2024 | 8.531M |
| March 25, 2024 | 8.689M |
| March 22, 2024 | 8.772M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
8.334M
Minimum
Mar 28 2024
160.44M
Maximum
Jun 11 2021
39.99M
Average
26.17M
Median
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 4.387M |
| Palatin Technologies Inc | 19.03M |
| iBio Inc | 28.91M |
| Theriva Biologics Inc | -10.98M |
| Oragenics Inc | 8.699M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.2923M |
| Revenue (Quarterly) | 0.053M |
| Total Expenses (Quarterly) | 0.4573M |
| EPS Diluted (Quarterly) | -0.001 |
| Profit Margin (Quarterly) | -551.7% |
| Earnings Yield | -370.0% |
| Normalized Earnings Yield | -258.56 |